Also trades as: 6127.HK (HKSE) · $vol 26M
603127.SS SHH
Joinn Laboratories(China)Co.,Ltd.
1W: +6.9%
1M: +6.1%
3M: +24.4%
YTD: +32.1%
1Y: +63.4%
3Y: +77.2%
5Y: -24.2%
¥49.30 ($7.35)
+4.48 (+10.00%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$9.4B
-6.3% ▼
5Y CAGR: +46.0%
Total Liabilities
$1.3B
-24.6% ▼
5Y CAGR: +17.4%
Shareholders Equity
$8.1B
-2.4% ▼
5Y CAGR: +57.8%
Cash & Investments
$2.4B
-27.0% ▼
5Y CAGR: +50.3%
Total Debt
$61M
+45.4% ▲
5Y CAGR: +22.3%
Net Debt
-$904M
+67.9% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $309M | $4.2B | $2.9B | $2.9B | $965M |
| Short-Term Investments | $239M | $681M | $408M | $373M | $1.4B |
| Cash & ST Investments | $548M | $4.8B | $3.3B | $3.2B | $2.4B |
| Net Receivables | $158M | $232M | $340M | $368M | $348M |
| Inventory | $406M | $701M | $2.2B | $1.9B | $1.5B |
| Other Current Assets | $71M | $8M | $65M | $1.5B | $779M |
| Total Current Assets | $1.2B | $5.8B | $5.9B | $7.1B | $5.0B |
| Property, Plant & Equip. | $494M | $705M | $945M | $1.5B | $1.1B |
| Goodwill & Intangibles | $249M | $260M | $433M | $428M | $437M |
| Long-Term Investments | -$174M | -$550M | $259M | $767M | -$680M |
| Other Non-Current Assets | $321M | $2.3B | $2.8B | $134M | $3.5B |
| Total Non-Current Assets | $925M | $2.7B | $4.4B | $2.9B | $4.4B |
| Total Assets | $2.1B | $8.5B | $10.4B | $10.0B | $9.4B |
| — Liabilities — | |||||
| Accounts Payable | $60M | $54M | $127M | $43M | $50M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $39M |
| Deferred Revenue | $692M | $1.1B | $1.3B | $1.2B | $0 |
| Other Current Liabilities | $592M | $32M | $34M | $32M | $999M |
| Total Current Liabilities | $760M | $1.2B | $1.8B | $1.5B | $1.1B |
| Long-Term Debt | $21M | $5M | $3M | $0 | $0 |
| Other Non-Current Liab. | $14M | $109M | $0 | $74M | $0 |
| Total Non-Current Liabilities | $124M | $178M | $329M | $279M | $206M |
| Total Liabilities | $884M | $1.4B | $2.2B | $1.7B | $1.3B |
| — Equity — | |||||
| Common Stock | $227M | $381M | $536M | $750M | $749M |
| Retained Earnings | $669M | $1.1B | $2.0B | $2.2B | $2.1B |
| Accumulated OCI | $112M | $110M | $175M | $0 | $0 |
| Total Stockholders Equity | $1.2B | $7.1B | $8.2B | $8.3B | $8.1B |
| Total Liabilities & Equity | $2.1B | $8.5B | $10.4B | $10.0B | $9.4B |
| — Key Metrics — | |||||
| Total Debt | $24M | $95M | $88M | $42M | $61M |
| Net Debt | -$284M | -$4.1B | -$2.8B | -$2.8B | -$904M |
| Total Investments | $64M | $131M | $667M | $1.1B | $716M |